FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743578360> ?p ?o ?g. }

• W2743578360 endingPage "1115" @default.
• W2743578360 startingPage "1104" @default.
• W2743578360 abstract "Abstract Background The benefits and risks of long-term testosterone administration have been a topic of much scientific and regulatory interest in recent years. Aim To assess long-term quality of life (QOL) and sexual function benefits of testosterone replacement therapy (TRT) prospectively in a diverse, multinational cohort of men with hypogonadism. Methods A multinational patient registry was used to assess long-term changes associated with TRT in middle-age and older men with hypogonadism. Comprehensive evaluations were conducted at 6, 12, 24, and 36 months after enrollment into the registry. Outcomes QOL and sexual function were evaluated by validated measures, including the Aging Males’ Symptom (AMS) Scale and the International Index of Erectile Function (IIEF). Results A total of 999 previously untreated men with hypogonadism were enrolled at 25 European centers, 750 of whom received TRT at at least one visit during the period of observation. Patients on TRT reported rapid and sustained improvements in QOL, with fewer sexual, psychological, and somatic symptoms. Modest improvements in QOL and sexual function, including erectile function, also were noted in RHYME patients not on TRT, although treated patients showed consistently greater benefit over time in all symptom domains compared with untreated patients. AMS total scores for patients on TRT were 32.8 (95% confidence interval = 31.3–34.4) compared with 36.6 (95% confidence interval = 34.8–38.5) for untreated patients (P &lt; .001). Small but significant improvements in IIEF scores over time also were noted with TRT. Approximately 25% of treated and untreated men also used phosphodiesterase type 5 inhibitors, with notable differences in the frequency of phosphodiesterase type 5 inhibitor prescription use according to physician specialty and geographic site location. Clinical Implications TRT-related benefits in QOL and sexual function are well maintained for up to 36 months after initiation of treatment. Strengths and Limitations The major strengths are the large, diverse patient population being treated in multidisciplinary clinical settings. The major limitation is the frequency of switching from one formulation to another. Conclusion Overall, we confirmed the broad and sustained benefits of TRT across major QOL dimensions, including sexual, somatic, and psychological health, which were sustained over 36 months in our treatment cohort." @default.
• W2743578360 created "2017-08-17" @default.
• W2743578360 creator A5004440946 @default.
• W2743578360 creator A5011653121 @default.
• W2743578360 creator A5012241174 @default.
• W2743578360 creator A5012941565 @default.
• W2743578360 creator A5024919772 @default.
• W2743578360 creator A5025451661 @default.
• W2743578360 creator A5025890613 @default.
• W2743578360 creator A5030447992 @default.
• W2743578360 creator A5031638435 @default.
• W2743578360 creator A5034937740 @default.
• W2743578360 creator A5043999711 @default.
• W2743578360 creator A5047045725 @default.
• W2743578360 creator A5049403397 @default.
• W2743578360 creator A5049759930 @default.
• W2743578360 creator A5059154237 @default.
• W2743578360 creator A5065137918 @default.
• W2743578360 creator A5065682345 @default.
• W2743578360 creator A5072935092 @default.
• W2743578360 creator A5078907933 @default.
• W2743578360 creator A5084954787 @default.
• W2743578360 creator A5088486376 @default.
• W2743578360 date "2017-08-03" @default.
• W2743578360 modified "2023-10-02" @default.
• W2743578360 title "Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)" @default.
• W2743578360 cites W1972618632 @default.
• W2743578360 cites W2018470562 @default.
• W2743578360 cites W2020336085 @default.
• W2743578360 cites W2033572273 @default.
• W2743578360 cites W2048958952 @default.
• W2743578360 cites W2052066994 @default.
• W2743578360 cites W2075287300 @default.
• W2743578360 cites W2079626238 @default.
• W2743578360 cites W2086240335 @default.
• W2743578360 cites W2088364786 @default.
• W2743578360 cites W2096237552 @default.
• W2743578360 cites W2110867597 @default.
• W2743578360 cites W2113388309 @default.
• W2743578360 cites W2118553855 @default.
• W2743578360 cites W2124283123 @default.
• W2743578360 cites W2127301944 @default.
• W2743578360 cites W2154659002 @default.
• W2743578360 cites W2165422473 @default.
• W2743578360 cites W2184195696 @default.
• W2743578360 cites W2203168867 @default.
• W2743578360 cites W2229446155 @default.
• W2743578360 cites W2276827618 @default.
• W2743578360 cites W2308565049 @default.
• W2743578360 cites W2324158400 @default.
• W2743578360 cites W2464449413 @default.
• W2743578360 cites W2472901376 @default.
• W2743578360 cites W2533904161 @default.
• W2743578360 doi "https://doi.org/10.1016/j.jsxm.2017.07.004" @default.
• W2743578360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28781213" @default.
• W2743578360 hasPublicationYear "2017" @default.
• W2743578360 type Work @default.
• W2743578360 sameAs 2743578360 @default.
• W2743578360 citedByCount "21" @default.
• W2743578360 countsByYear W27435783602018 @default.
• W2743578360 countsByYear W27435783602019 @default.
• W2743578360 countsByYear W27435783602020 @default.
• W2743578360 countsByYear W27435783602021 @default.
• W2743578360 countsByYear W27435783602022 @default.
• W2743578360 countsByYear W27435783602023 @default.
• W2743578360 crossrefType "journal-article" @default.
• W2743578360 hasAuthorship W2743578360A5004440946 @default.
• W2743578360 hasAuthorship W2743578360A5011653121 @default.
• W2743578360 hasAuthorship W2743578360A5012241174 @default.
• W2743578360 hasAuthorship W2743578360A5012941565 @default.
• W2743578360 hasAuthorship W2743578360A5024919772 @default.
• W2743578360 hasAuthorship W2743578360A5025451661 @default.
• W2743578360 hasAuthorship W2743578360A5025890613 @default.
• W2743578360 hasAuthorship W2743578360A5030447992 @default.
• W2743578360 hasAuthorship W2743578360A5031638435 @default.
• W2743578360 hasAuthorship W2743578360A5034937740 @default.
• W2743578360 hasAuthorship W2743578360A5043999711 @default.
• W2743578360 hasAuthorship W2743578360A5047045725 @default.
• W2743578360 hasAuthorship W2743578360A5049403397 @default.
• W2743578360 hasAuthorship W2743578360A5049759930 @default.
• W2743578360 hasAuthorship W2743578360A5059154237 @default.
• W2743578360 hasAuthorship W2743578360A5065137918 @default.
• W2743578360 hasAuthorship W2743578360A5065682345 @default.
• W2743578360 hasAuthorship W2743578360A5072935092 @default.
• W2743578360 hasAuthorship W2743578360A5078907933 @default.
• W2743578360 hasAuthorship W2743578360A5084954787 @default.
• W2743578360 hasAuthorship W2743578360A5088486376 @default.
• W2743578360 hasBestOaLocation W27435783602 @default.
• W2743578360 hasConcept C126322002 @default.
• W2743578360 hasConcept C159110408 @default.
• W2743578360 hasConcept C2775871022 @default.
• W2743578360 hasConcept C2778093883 @default.
• W2743578360 hasConcept C2779279991 @default.
• W2743578360 hasConcept C2779929075 @default.
• W2743578360 hasConcept C2779951463 @default.
• W2743578360 hasConcept C29456083 @default.
• W2743578360 hasConcept C44249647 @default.
• W2743578360 hasConcept C71924100 @default.

• next